Literature DB >> 19755138

Modulation of ER alpha transcriptional activity by the orphan nuclear receptor ERR beta and evidence for differential effects of long- and short-form splice variants.

Vincent Bombail1, Frances Collins, Pamela Brown, Philippa T K Saunders.   

Abstract

Oestrogen receptor related proteins (ERRs) affect target gene expression without binding oestradiol. We investigated the functional activity of two splice variant isoforms of ERR beta (ERR beta S [short], ERR beta L [long]) expressed in human endometrium, where they are coexpressed with the oestrogen receptor alpha (ER alpha). Over-expression of ERRbetaL enhanced ER alpha-dependent ligand-induced activation of an ERE-luciferase reporter construct, altered the induction of c-myc mRNA and increased proliferation of Ishikawa cells whereas ERR beta S was found to reduce these endpoints. Fluorescent recovery after photobleaching (FRAP) revealed that intra-nuclear mobility of YFP-ERR beta S was more rapid than YFP-ERR beta L. Fluorescence resonance energy transfer (FRET) assays revealed a close association between ERR beta L and ER alpha following addition of ligand. We speculate that ERR beta L may alter ER alpha-dependent gene activation by enhancing the recruitment of co-activators. In conclusion, variant isoforms of ERR beta have differential effects on ER alpha-dependent gene expression and this has implications for human endometrial cell function.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19755138     DOI: 10.1016/j.mce.2009.09.007

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  13 in total

Review 1.  Function of alternative splicing.

Authors:  Olga Kelemen; Paolo Convertini; Zhaiyi Zhang; Yuan Wen; Manli Shen; Marina Falaleeva; Stefan Stamm
Journal:  Gene       Date:  2012-08-15       Impact factor: 3.688

2.  Estrogen-related Receptor β Reduces the Subnuclear Mobility of Estrogen Receptor α and Suppresses Estrogen-dependent Cellular Function.

Authors:  Takashi Tanida; Ken Ichi Matsuda; Shunji Yamada; Takashi Hashimoto; Mitsuhiro Kawata
Journal:  J Biol Chem       Date:  2015-03-24       Impact factor: 5.157

Review 3.  Molecular dynamics of estrogen-related receptors and their regulatory proteins: roles in transcriptional control for endocrine and metabolic signaling.

Authors:  Takashi Tanida
Journal:  Anat Sci Int       Date:  2021-10-05       Impact factor: 1.741

4.  Messenger RNA profile analysis deciphers new Esrrb responsive genes in prostate cancer cells.

Authors:  Yuan Lu; Jilong Li; Jianlin Cheng; Dennis B Lubahn
Journal:  BMC Mol Biol       Date:  2015-12-01       Impact factor: 2.946

5.  Overexpression of caspase 7 is ERα dependent to affect proliferation and cell growth in breast cancer cells by targeting p21(Cip).

Authors:  S Chaudhary; B Madhukrishna; A K Adhya; S Keshari; S K Mishra
Journal:  Oncogenesis       Date:  2016-04-18       Impact factor: 7.485

Review 6.  Steroid regulation of menstrual bleeding and endometrial repair.

Authors:  Jacqueline A Maybin; Hilary O D Critchley
Journal:  Rev Endocr Metab Disord       Date:  2012-12       Impact factor: 6.514

7.  ERRβ signalling through FST and BCAS2 inhibits cellular proliferation in breast cancer cells.

Authors:  D Sengupta; D K Bhargava; A Dixit; B S Sahoo; S Biswas; G Biswas; S K Mishra
Journal:  Br J Cancer       Date:  2014-03-25       Impact factor: 7.640

8.  ERRβ splice variants differentially regulate cell cycle progression.

Authors:  Mary Mazzotta Heckler; Rebecca B Riggins
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

Review 9.  Estrogen-related receptor β (ERRβ) - renaissance receptor or receptor renaissance?

Authors:  Shailaja D Divekar; Deanna M Tiek; Aileen Fernandez; Rebecca B Riggins
Journal:  Nucl Recept Signal       Date:  2016-06-21

10.  Antimitotic activity of DY131 and the estrogen-related receptor beta 2 (ERRβ2) splice variant in breast cancer.

Authors:  Mary M Heckler; Tizita Zewde Zeleke; Shailaja D Divekar; Aileen I Fernandez; Deanna M Tiek; Jordan Woodrick; Alexander Farzanegan; Rabindra Roy; Aykut Üren; Susette C Mueller; Rebecca B Riggins
Journal:  Oncotarget       Date:  2016-07-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.